For knowledge institutes, creating and out-licensing intellectual property rights are daily practice. Your institute has to negotiate with large pharmaceutical companies, venture capitalists, initiators of spin-out companies, and with its own scientists who wish to publish. Oftentimes, a knowledge institute feels squeezed between the interests of its stakeholders and others involved. It is not easy to find a balance between accelerating the valorisation of knowledge and ensuring that your institute is not left empty-handed.
Axon Lawyers has many years of experience in drafting and negotiating intellectual property driven agreements and spin-out agreements that safeguard research licenses. We are familiar with the market and its customs. Our clients include renowned knowledge institutes, venture capitalist, and biotech companies. Therefore, we can easily imagine other stakeholders’ positions and adequately facilitate arriving at satisfying agreements.